Impact of Combination Immunotherapy with Tumor Treating Fields Therapy In A Glioma Cohort

Yazmin Odia

Impact of Combination Immunotherapy with Tumor Treating Fields Therapy In A Glioma Cohort

Yazmin Odia

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - 2017
Event	Society for NeuroOncology (SNO) 22nd Annual Meeting and Education Day - San Francisco, CA Duration: Jan 1 2017 → …

Conference

Conference	Society for NeuroOncology (SNO) 22nd Annual Meeting and Education Day
Period	1/1/17 → …

Disciplines

Medicine and Health Sciences
Neoplasms
Neurology
Oncology

Cite this

@conference{e3d17d05fc32480b8d23d0dc4954b6c3,

title = "Impact of Combination Immunotherapy with Tumor Treating Fields Therapy In A Glioma Cohort",

author = "Yazmin Odia",

note = "Abstract. Tumor-treating fields (TTF) increase patient survival in glioblastoma, and are approved for recurrent (2011) and de novotumors (2016). Since 2012, 52; Society for NeuroOncology (SNO) 22nd Annual Meeting and Education Day ; Conference date: 01-01-2017",

year = "2017",

language = "American English",

}

TY - CONF

T1 - Impact of Combination Immunotherapy with Tumor Treating Fields Therapy In A Glioma Cohort

AU - Odia, Yazmin

N1 - Abstract. Tumor-treating fields (TTF) increase patient survival in glioblastoma, and are approved for recurrent (2011) and de novotumors (2016). Since 2012, 52

PY - 2017

Y1 - 2017

UR - https://academic.oup.com/neuro-oncology/article/19/suppl_6/vi221/4591320

M3 - Presentation

T2 - Society for NeuroOncology (SNO) 22nd Annual Meeting and Education Day

Y2 - 1 January 2017

ER -

Impact of Combination Immunotherapy with Tumor Treating Fields Therapy In A Glioma Cohort

Conference

Disciplines

Other files and links

Cite this